Isomorphic Labs
Isomorphic Labs provides AI-driven solutions for drug discovery and development.
About Isomorphic Labs
Isomorphic Labs focuses on drug discovery using artificial intelligence. The company develops innovative platforms that analyze biological data to identify potential drug candidates. It offers tools that assist researchers in understanding complex biological systems and predicting the effects of various compounds. Isomorphic Labs collaborates with pharmaceutical companies to streamline the drug development process, enhancing efficiency and accuracy. The company’s services include data analysis, modeling, and simulation to support research and development efforts.
Company Facts
- Headquarters
- London
- Operating Status
- active
- Company Type
- for_profit
- IPO Status
- private
- Employees
- c_00101_00250
- Funding Stage
- early_stage_venture
- Total Funding
- $601,654,000
- Last Funding Type
- series_a
- Last Funding Date
- 2025-03-31
- Website
- isomorphiclabs.com
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Life Science, Medical
Social Links
Canonical: https://fsome.com/organization/isomorphic-labs-9612 · For the full interactive profile (funding rounds, investors, team, portfolio, charts), please enable JavaScript.